Treatt has announced the appointment of Manprit Randhawa as its interim chief financial officer (CFO) designate.

The company confirmed the move will be effective from 8 September 2025.

Treatt, which manufactures natural extracts and ingredients for the beverage, flavour, fragrance markets, has also confirmed that Ryan Govender will step down as CFO on 30 September, after completing a handover period to Randhawa.

Randhawa has 20 years’ experience in finance across a variety of industries including manufacturing, life sciences, retail and professional services. He is joining Treatt from SkinBioTherapeutics, an AIM listed life science company focused on skin health.

Chair of Treatt, Vijay Thakrar, commented: “We are delighted to welcome Manprit as interim CFO. He brings a wealth of strategic and commercial expertise to Treatt, and we look forward to working with him.”

---